MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression

miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers

(2017) Insaf Fkih M’hamed et al.   PATHOLOGY & ONCOLOGY RESEARCH

Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer

(2016) Maciej Bobowicz et al.   CLINICAL & EXPERIMENTAL METASTASIS

microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma

(2016) Chuanying Zhu et al.   LIFE SCIENCES

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

(2016) Giampaolo Bianchini et al.   Nature Reviews Clinical Oncology

Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients

(2016) Yanwei Luo et al.   Oncology Letters

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer

(2016) Jingdan Qiu et al.   Journal of Cancer

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

(2016) Brian D. Lehmann et al.   PLoS One

RETRACTED ARTICLE: Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma

(2015) Alireza Mirghasemi et al.   Cancer Cell International

Breast Cancer beyond the Age of Mutation

(2015) Mark A. LaBarge et al.   GERONTOLOGY

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer

(2015) Andrea Mathe et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer

(2015) Jason B. Ross et al.   NATURE CELL BIOLOGY

Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling Pathways

(2015) Yuping Liu et al.   PLoS One

High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer

(2015) Li Chen et al.   PLoS One

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

(2015) Nicole M. Davis et al.   Oncotarget

Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance

(2014) E. Y. Park et al.   CANCER RESEARCH

Targeting beta-Catenin signaling to induce apoptosis in human breast cancer cells by z-Guggulsterone and Gugulipid extract of Ayurvedic medicine plant Commiphora mukul

(2013) Guoqin Jiang et al.   BMC Complementary and Alternative Medicine

Identification of Circulating MicroRNA Signatures for Breast Cancer Detection

(2013) M. Chan et al.   CLINICAL CANCER RESEARCH

A Risk Variant in an miR-125b Binding Site in BMPR1B Is Associated with Breast Cancer Pathogenesis

(2009) P. Saetrom et al.   CANCER RESEARCH

A Short Hairpin DNA Analogous to miR-125b Inhibits C-Raf Expression, Proliferation, and Survival of Breast Cancer Cells

(2009) M. H. Hofmann et al.   MOLECULAR CANCER RESEARCH

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

MicroRNAs and cancer: past, present, and potential future

(2008) K. M. Nelson et al.   MOLECULAR CANCER THERAPEUTICS